Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients

Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients

Abstract Background Less than 20 % of patients with resectable oesophageal adenocarcinoma obtain a pathological response following neoadjuvant chemotherapy. Studies using oesophageal cancer cell lines have shown that drug sensitive tumour cells undergo apoptosis in response to drug treatment, wherea...

Full description

Bibliographic Details
Main Authors: Shereen El Mashed, Tracey R. O’Donovan, Elaine Kay, Anthony O’Grady, Damian McManus, Richard C. Turkington, Sharon L. McKenna
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Cancer
Subjects:
Caspase-3
autophagy
LC3B
oesophageal adenocarcinoma
predictive biomarkers
Online Access:https://doi.org/10.1186/s12885-022-09981-8

Internet

https://doi.org/10.1186/s12885-022-09981-8

Similar Items